questionText: To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Welsh Minister for Health and Social Services on the availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other ADHD me
answerText: Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working ...
heading: Attention Deficit Hyperactivity Disorder: Drugs